| Apokyn (apomorphine bolus injection) / Stada, Supernus Pharma, Aguettant |
2010-019198-14: Icke-motoriska och hälsoekonomiska effekter av intermittent subkutan apomorfinbehandling vid Parkinsons sjukdom |
|
|
| Ongoing | 4 | 30 | Europe | Apo-GO Pen, Apo-GO Pen, Apo-GO Pen | Karolinska Universitetssjukhuset Huddinge | Parkinsons sjukdom | | | | |
APOMORPHEE, NCT02940912: Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease |
|
|
| Completed | 4 | 45 | Europe | Apomorphine, Apokinon, Placebo, Physiologic Serum | Clinique Beau Soleil | Parkinson Disease | 01/21 | 04/21 | | |
2010-018650-12: Evaluation du système noradrénergique dans l’altération de la perception douloureuse chez le patient Parkinsonien |
|
|
| Ongoing | 3 | 36 | Europe | duloxetine, apomorphine, levodopa, dompéridone, CYMBALTA, APOKINON, MODOPAR, MOTILIUM, CYMBALTA, APOKINON, MODOPAR, MOTILIUM | CHU de Toulouse | maladie de Parkinson | | | | |
2016-002454-20: Apomorphine Pump in Early Stage of Parkinson’s Disease Pompe à apomorphine au stade précoce de la maladie de Parkinson |
|
|
| Ongoing | 3 | 192 | Europe | APOKINON, Solution for infusion, APOKINON | CHU de Rennes, CHU de Rennes | Parkinson’s disease Maladie de Parkinson, Parkinson’s disease Maladie de Parkinson, Diseases [C] - Nervous System Diseases [C10] | | | | |
| Active, not recruiting | 3 | 134 | Europe | Apomorphine, Apokinon, Best Medical Treatment | Rennes University Hospital | Parkinson's Disease | 12/23 | 01/25 | | |
2004-001929-20: EL TEST DE APOMORFINA COMO MARCADOR BIOLÓGICO DE LAS RECAÍDAS EN PACIENTES DEPENDIENTES DE SUSTANCIAS PSICOTROPAS |
|
|
| Ongoing | 2 | 180 | Europe | Ialoprida, APO-go PEN 10 mg/ml solución inyectable, 123I-IBZM, APO-go PEN 10 mg/ml solución inyectable, 123I-IBZM | Servicio de Psiquiatría. Hospital Universitari Vall dHebron | Dependencia de alcoholDependencia de cocaínaDependencia de heroína | | | | |